Skip to main content

Table 1 Baseline Data For all Pediatric Patients (1–12 years old, X ± SD)

From: Postoperative analgesia for pediatric craniotomy patients: a randomized controlled trial

 

1–6 Years Old Patients

7–12 Years Old Patients

Group C

Group F

Group M

Group T

Group C

Group F

Group M

Group T

Age (yr)

4.00 ± 1.77

3.50 ± 1.54

4.05 ± 1.45

3.70 ± 1.64

8.97 ± 2.92

9.21 ± 1.68

8.51 ± 2.69

9.29 ± 1.60

Sex (male/female)

24/16

27/13

24/16

22/18

25/15

18/22

24/16

24/16

Height (m)

1.07 ± 0.16

1.03 ± 0.13

1.05 ± 0.11

1.06 ± 0.14

1.42 ± 0.15

1.33 ± 0.13

1.38 ± 0.14

1.40 ± 0.13

Weight (kg)

19.8 ± 5.4

17.4 ± 4.7

18.9 ± 6.0

18.3 ± 6.3

37.7 ± 15.5

32.6 ± 8.5

34.6 ± 10.9

36.12 ± 11.5

Craniotomy site(n / %)

 Forehead

24 (60)

19 (47.5)

18 (45)

17 (42.5)

22 (55.0)

23 (57.5)

21 (52.5)

19 (47.5)

 Frontotemporal

2 (5)

6 (15)

9 (22.5)

3 (7.5)

4 (10.0)

3 (7.5)

7 (17.5)

5 (12.5)

 Frontoparietal

1 (2.5)

1 (2.5)

2 (5)

2 (5)

3 (7.5)

2 (5.0)

2 (5.0)

3 (7.5)

 Temporal occipital

1 (2.5)

0 (0)

1 (2.5)

2 (5)

1 (2.5)

0 (0.0)

1 (2.5)

1 (2.5)

 Occipital

11 (27.5)

11 (27.5)

9 (22.5)

15 (37.5)

10 (25)

11 (27.5)

8 (20.0)

11 (27.5)

 Temporal-parietal occipital

1 (2.5)

3 (7.5)

1 (2.5)

1 (2.5)

0 (0.0)

1 (2.5)

1 (2.5)

1 (2.5)

VP shunt surgery (Y/N)

5/35

8/32

7/33

7/33

7/33

4/36

1/39

7/33

Durations of surgery (min)

217 ± 81

229 ± 112

212 ± 67

215 ± 63

299 ± 59

205 ± 134

219 ± 49

229 ± 60

Durations of anesthesia (min)

320 ± 98

403 ± 73

310 ± 80

308 ± 74

331 ± 77

290 ± 81

311 ± 63

328 ± 66

Bleeding (ml)

161 ± 199

109 ± 72

136 ± 168

118 ± 93

133 ± 80

113 ± 95

163 ± 141

129 ± 80

Anesthesia maintenance phase

 Propofol (mg)

225 (155, 337)

190 (140, 367)

230 (160, 300)

220 (152, 340)

525 (292, 672)

350 (215, 555)

340 (200, 490)

280 (160, 480)

 Remifentanil (mg)

0.63 ± 0.34

0.61 ± 0.46

0.49 ± 0.25

0.68 ± 0.36

1.07 ± 0.59

0.82 ± 0.45

0.91 ± 0.57

1.24 ± 1.44

 Sevoflurane (ml)

30 ± 20

28 ± 22

28 ± 13

24 ± 13

29 ± 12

22 ± 12

26 ± 11

27 ± 11

  1. No significant difference of baseline characteristics was observed